Durvalumab(MEDI4736) and AZD6738 Combination Therapy in Relapsed Small Cell Lung Cancer Subjects
Clinical trial NCT04361825 · COMPLETED
Trial details
- NCT number
- NCT04361825
- Sponsor
- Se-Hoon Lee
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-06-17
- Primary completion
- 2023-10-25
- Enrollment
- 42
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.